Donating Tissue for Research: Patient and Provider Perspectives

著者: Baer, Allison R., Smith, Mary Lou, Bendell, Johanna C.
出版事項 2011

A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer

著者: Patel, Manish R., Falchook, Gerald S., Hamada, Kensuke, Makris, Lukas, Bendell, Johanna C.
出版年 Cancer Med (2021)

Targeted Therapy in Rectal Cancer

著者: WILLETT, CHRISTOPHER G., DUDA, DAN G., CZITO, BRIAN G., BENDELL, JOHANNA C., CLARK, JEFFREY W., JAIN, RAKESH K.
出版事項 2007

Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors

著者: Bendell, Johanna C., Patel, Manish R., Moore, Kathleen N., Chua, Cynthia C., Arkenau, Hendrik‐Tobias, Dukart, Gary, Harrow, Kim, Liang, Chris
出版年 Oncologist (2018)

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

著者: Wong, Nan Soon, Fernando, Nishan H., Bendell, Johanna C., Morse, Michael A., Blobe, Gerard C., Honeycutt, Wanda, Pang, Herbert, Hurwitz, Herbert I.
出版事項 2011

Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors

著者: Bendell, Johanna C., Patel, Manish R., Yoshida, Kenichiro, Seraj, Jabed, Weaver, Racquel, Lemech, Charlotte, Todaro, Thomas G., Pant, Shubham, Arkenau, Hendrik-Tobias
出版年 Cancer Chemother Pharmacol (2016)

A Phase II Study with Lead‐In Safety Cohort of 5‐Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized...

著者: Shepard, Gregg, Arrowsmith, Edward R., Murphy, Patrick, Barton, John H., Peyton, James D., Mainwaring, Mark, Blakely, Laura, Maun, Noel A., Bendell, Johanna C.
出版年 Oncologist (2017)

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors

著者: Moore, Kathleen N., Bendell, Johanna C., LoRusso, Patricia M., Olszanski, Anthony J., Zwick-Wallasch, Esther, Jansen, Mendel, Vandell, Alexander G., Senaldi, Giorgio
出版年 Invest New Drugs (2018)

A Phase I Study of Gemcitabine + Dasatinib (GD) or Gemcitabine + Dasatinib + Cetuximab (GDC) in Refractory Solid Tumors

著者: Mettu, Niharika B, Niedzwiecki, Donna, Rushing, Christel, Nixon, Andrew B., Jia, Jingquan, Haley, Sherri, Honeycutt, Wanda, Hurwitz, Herbert, Bendell, Johanna C., Uronis, Hope
出版年 Cancer Chemother Pharmacol (2019)

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

著者: Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
出版年 Cancer Chemother Pharmacol (2015)

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer

著者: Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
出版年 Cancer Chemother Pharmacol (2015)

A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors

著者: Pant, Shubham, Burris, Howard A., Moore, Kathleen, Bendell, Johanna C., Kurkjian, Carla, Jones, Suzanne F., Moreno, Ofir, Kuhn, John G., McMeekin, Scott, Infante, Jeffrey R.
出版事項 2013

Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohor...

著者: Burris, Howard A, Bakewell, Suzanne, Bendell, Johanna C, Infante, Jeffrey, Jones, Suzanne F, Spigel, David R, Weiss, Glen J, Ramanathan, Ramesh K, Ogden, Angela, Von Hoff, Daniel
出版年 ESMO Open (2017)

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

著者: Bendell, Johanna C., Zakari, Ahmed, Peyton, James D., Boccia, Ralph, Moskowitz, Mark, Gian, Victor, Lipman, Andrew, Waterhouse, David, LoCicero, Richard, Earwood, Chris, Lane, Cassie M., Meluch, Anthony
出版年 Oncologist (2016)

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES, a Bevac...

著者: Bendell, Johanna C., Bekaii-Saab, Tanios S., Cohn, Allen L., Hurwitz, Herbert I., Kozloff, Mark, Tezcan, Haluk, Roach, Nancy, Mun, Yong, Fish, Susan, Flick, E. Dawn, Dalal, Darshan, Grothey, Axel
出版事項 2012

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial

著者: Infante, Jeffrey R., Arkenau, Hendrik-Tobias, Bendell, Johanna C., Rubin, Mark S., Waterhouse, David, Jones, George Tripp, Spigel, David R., Lane, Cassie M., Hainsworth, John D., Burris III, Howard A.
出版事項 2013

A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

著者: WONG, NAN SOON, FERNANDO, NISHAN H., NIXON, ANDREW B., CUSHMAN, STEPHANIE, AKLILU, MEBEA, BENDELL, JOHANNA C., MORSE, MICHAEL A., BLOBE, GERARD C., ASHTON, JILL, PANG, HERBERT, HURWITZ, HERBERT I.
出版事項 2011

Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacokinetics Study of ME-344 as a Single Agent in Patients With Refractory Solid Tumors

著者: Bendell, Johanna C, Patel, Manish R, Infante, Jeffrey R, Kurkjian, Carla D, Jones, Suzanne F, Pant, Shubham, Burris, Howard A, Moreno, Ofir, Esquibel, Vanessa, Levin, Wendy, Moore, Kathleen N
出版年 Cancer (2015)

A Phase II Trial of Bevacizumab plus Everolimus for Patients with Refractory Metastatic Colorectal Cancer

著者: Altomare, Ivy, Bendell, Johanna C., Bullock, Karen E., Uronis, Hope E., Morse, Michael A., Hsu, S. David, Zafar, S. Yousuf, Blobe, Gerard C., Pang, Herbert, Honeycutt, Wanda, Sutton, Linda, Hurwitz, Herbert I.
出版事項 2011

Phase Ib Study of the Mitochondrial Inhibitor ME-344 Plus Topotecan in Patients with Previously Treated, Locally Advanced or Metastatic Small Cell Lung, Ovarian and Cervical Cancer...

著者: Diamond, Jennifer R., Goff, Barbara, Forster, Martin D., Bendell, Johanna C., Britten, Carolyn D., Gordon, Michael S., Gabra, Hani, Waterhouse, David M., Poole, Mark, Camidge, D. Ross, Hamilton, Erika, Moore, Kathleen M.
出版年 Invest New Drugs (2017)